FXR Overexpression Prevents Hepatic Steatosis Through Inhibiting AIM2 Inflammasome Activation in Alcoholic Liver Disease

Overview

Journal Hepatol Int

Publisher Springer

Specialty Gastroenterology

Date 2024 Jan 6

PMID 38183609

Authors

Lin Li

Lina Kong

Shuai Xu

Changyuan Wang

Jiangning Gu

Haifeng Luo

Qiang Meng

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Alcoholic liver disease (ALD), a metabolic liver disease caused by excessive alcohol consumption, has attracted increasing attention due to its high prevalence and mortality. Up to date, there is no effective and feasible treatment method for ALD. This study was to investigate whether Farnesoid X receptor (FXR, NR1H4) can alleviate ALD and whether this effect is mediated by inhibiting absent in melanoma 2 (AIM2) inflammasome activation.

Methods: The difference in FXR expression between normal subjects and ALD patients was analyzed using the Gene Expression Omnibus (GEO) database. Lieber-DeCarli liquid diet with 5% ethanol (v/v) (EtOH) was adopted to establish the mouse ALD model. Liver histopathological changes and the accumulation of lipid droplets were assessed by H&E and Oil Red O staining. Quantitative real-time PCR, Western blotting analysis and immunofluorescence staining were utilized to evaluate the expression levels of related genes and proteins. DCFH-DA staining was adopted to visualize reactive oxidative species (ROS).

Results: FXR was distinctly downregulated in liver tissues of patients with steatosis compared to normal livers using the GEO database, and in ethanol-induced AML-12 cellular steatosis model. FXR overexpression ameliorated hepatic lipid metabolism disorder and steatosis induced by ethanol by inhibiting the expression of genes involved in lipid synthesis and inducing the expression of genes responsible for lipid metabolism. Besides, FXR overexpression inhibited ethanol-induced AIM2 inflammasome activation and alleviated oxidative stress and ROS production during ethanol-induced hepatic steatosis. However, when FXR was knocked down, the results were completely opposite.

Conclusions: FXR attenuated lipid metabolism disorders and lipid degeneration in alcohol-caused liver injury and alleviated oxidative stress and inflammation by inhibiting AIM2 inflammasome activation.

Citing Articles

Investigation of Uncovering Molecular Mechanisms of Alcohol-Induced Female Infertility-A Rational Approach.

Lubau N, Chengebroyen N, Subramaniyan V Reprod Sci. 2024; 31(12):3660-3672.

PMID: 39485609 PMC: 11611948. DOI: 10.1007/s43032-024-01692-8.

References

Guo M, Gu L, Hui H, Li X, Jin L . Extracts of Maxim Ameliorate Acute Alcoholic Liver Disease Regulating Transcription Factors in Mice. Front Pharmacol. 2022; 13:830532. PMC: 8966672. DOI: 10.3389/fphar.2022.830532. View

Wen B, Zhang C, Zhou J, Zhang Z, Che Q, Cao H . Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacol Ther. 2020; 222:107752. DOI: 10.1016/j.pharmthera.2020.107752. View

Heo M, Kim T, You J, Blaya D, Sancho-Bru P, Kim S . Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression. Gut. 2018; 68(4):708-720. PMC: 6581021. DOI: 10.1136/gutjnl-2017-315123. View

Louvet A, Mathurin P . Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015; 12(4):231-42. DOI: 10.1038/nrgastro.2015.35. View

Sun J, Fu J, Li L, Chen C, Wang H, Hou Y . Nrf2 in alcoholic liver disease. Toxicol Appl Pharmacol. 2018; 357:62-69. DOI: 10.1016/j.taap.2018.08.019. View

Li Y, Chen M, Zhou Y, Tang C, Zhang W, Zhong Y . NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease. Theranostics. 2020; 10(8):3579-3593. PMC: 7069072. DOI: 10.7150/thno.40149. View

Rao P, Shen Y, Song Y, Xu Y, Xu H . Prunella vulgaris L. attenuates gut dysbiosis and endotoxin leakage against alcoholic liver disease. J Ethnopharmacol. 2023; 319(Pt 2):117237. DOI: 10.1016/j.jep.2023.117237. View

Hu M, Chen Y, Deng F, Chang B, Luo J, Dong L . D-Mannose Regulates Hepatocyte Lipid Metabolism PI3K/Akt/mTOR Signaling Pathway and Ameliorates Hepatic Steatosis in Alcoholic Liver Disease. Front Immunol. 2022; 13:877650. PMC: 9021718. DOI: 10.3389/fimmu.2022.877650. View

Rangwala F, Guy C, Lu J, Suzuki A, Burchette J, Abdelmalek M . Increased production of sonic hedgehog by ballooned hepatocytes. J Pathol. 2011; 224(3):401-10. PMC: 3628812. DOI: 10.1002/path.2888. View

10.

Forman B, Goode E, Chen J, Oro A, Bradley D, Perlmann T . Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 1995; 81(5):687-93. DOI: 10.1016/0092-8674(95)90530-8. View

11.

Fu T, Li Y, Oh T, Cayabyab F, He N, Tang Q . FXR mediates ILC-intrinsic responses to intestinal inflammation. Proc Natl Acad Sci U S A. 2022; 119(51):e2213041119. PMC: 9907109. DOI: 10.1073/pnas.2213041119. View

12.

Ma S, Pang X, Tian S, Sun J, Hu Q, Li X . The protective effects of sulforaphane on high-fat diet-induced metabolic associated fatty liver disease in mice mediating the FXR/LXRα pathway. Food Funct. 2022; 13(24):12966-12982. DOI: 10.1039/d2fo02341e. View

13.

Wang J, Zhang M, Luo M, Qin S, Xia X . Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats. Sci Rep. 2022; 12(1):18873. PMC: 9640703. DOI: 10.1038/s41598-022-23539-5. View

14.

Cui Z, Han X, Jiang Y, Dou J, Yao K, Hu Z . L. Extracts Promote Activity of FXR to Ameliorate Alcoholic Liver Disease: Targeting Liver Lipid Deposition and Inflammation. Front Pharmacol. 2021; 12:738689. PMC: 8531498. DOI: 10.3389/fphar.2021.738689. View

15.

Xu Z, Tang W, Xie Q, Cao X, Zhang M, Zhang X . Dimethyl fumarate attenuates cholestatic liver injury by activating the NRF2 and FXR pathways and suppressing NLRP3/GSDMD signaling in mice. Exp Cell Res. 2023; 432(2):113781. DOI: 10.1016/j.yexcr.2023.113781. View

16.

Cariou B . The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis. Diabetes Metab. 2009; 34(6 Pt 2):685-91. DOI: 10.1016/S1262-3636(08)74605-6. View

17.

Cao T, Yuan X, Fang H, Chen J, Xue K, Li Z . Neutrophil extracellular traps promote keratinocyte inflammation via AIM2 inflammasome and AIM2-XIAP in psoriasis. Exp Dermatol. 2022; 32(4):368-378. DOI: 10.1111/exd.14711. View

18.

Chen C, Liu Y, Cheng S, Wu S, Zhai X . The hepatoprotective effects of XCHD and MgIG against methotrexate-induced liver injury and inflammation in rats through suppressing the activation of AIM2 inflammasomes. Pathol Res Pract. 2020; 216(4):152875. DOI: 10.1016/j.prp.2020.152875. View

19.

Valencia-Ortega J, Gonzalez-Reynoso R, Salcedo-Vargas M, Diaz-Velazquez M, Ramos-Martinez E, Ferreira-Hermosillo A . Differential Expression of FXR and Genes Involved in Inflammation and lipid Metabolism Indicate Adipose Tissue Dysfunction in Gestational Diabetes. Arch Med Res. 2023; 54(3):189-196. DOI: 10.1016/j.arcmed.2023.02.004. View

20.

Chu J, Yan R, Wang S, Li G, Kang X, Hu Y . Sinapic Acid Reduces Oxidative Stress and Pyroptosis via Inhibition of BRD4 in Alcoholic Liver Disease. Front Pharmacol. 2021; 12:668708. PMC: 8212038. DOI: 10.3389/fphar.2021.668708. View